NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock - Currency: USD
NASDAQ:WGS (5/7/2025, 12:13:05 PM)
58.427
-4.84 (-7.65%)
The current stock price of WGS is 58.427 USD. In the past month the price decreased by -25.36%. In the past year, price increased by 204.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.03 | 90.07B | ||
CVS | CVS HEALTH CORP | 10.42 | 83.66B | ||
LH | LABCORP HOLDINGS INC | 16.74 | 20.64B | ||
DGX | QUEST DIAGNOSTICS INC | 19.19 | 19.69B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 17.82 | 16.73B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 127.1 | 13.80B | ||
HIMS | HIMS & HERS HEALTH INC | 71.52 | 11.04B | ||
DVA | DAVITA INC | 15.06 | 11.00B | ||
CHE | CHEMED CORP | 24.6 | 8.48B | ||
CRVL | CORVEL CORP | 26.86 | 5.77B | ||
OPCH | OPTION CARE HEALTH INC | 24.14 | 5.38B | ||
GH | GUARDANT HEALTH INC | N/A | 4.95B |
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through the GeneDx segment. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. The company provides carrier/variant-specific testing, targeted mosaic variant testing, and others.
GENEDX HOLDINGS CORP
333 Ludlow Street, North Tower, 6Th Floor
Stamford CONNECTICUT US
Employees: 1000
Phone: 18887291206
The current stock price of WGS is 58.427 USD. The price decreased by -7.65% in the last trading session.
The exchange symbol of GENEDX HOLDINGS CORP is WGS and it is listed on the Nasdaq exchange.
WGS stock is listed on the Nasdaq exchange.
10 analysts have analysed WGS and the average price target is 98.6 USD. This implies a price increase of 68.76% is expected in the next year compared to the current price of 58.427. Check the GENEDX HOLDINGS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GENEDX HOLDINGS CORP (WGS) has a market capitalization of 1.67B USD. This makes WGS a Small Cap stock.
GENEDX HOLDINGS CORP (WGS) currently has 1000 employees.
GENEDX HOLDINGS CORP (WGS) has a support level at 62.92. Check the full technical report for a detailed analysis of WGS support and resistance levels.
The Revenue of GENEDX HOLDINGS CORP (WGS) is expected to grow by 23.68% in the next year. Check the estimates tab for more information on the WGS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
WGS does not pay a dividend.
GENEDX HOLDINGS CORP (WGS) will report earnings on 2025-07-28, after the market close.
The PE ratio for GENEDX HOLDINGS CORP (WGS) is 69.56. This is based on the reported non-GAAP earnings per share of 0.84 and the current share price of 58.427 USD. Check the full fundamental report for a full analysis of the valuation metrics for WGS.
The outstanding short interest for GENEDX HOLDINGS CORP (WGS) is 13.03% of its float. Check the ownership tab for more information on the WGS short interest.
ChartMill assigns a technical rating of 4 / 10 to WGS. When comparing the yearly performance of all stocks, WGS is one of the better performing stocks in the market, outperforming 98.71% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to WGS. The financial health of WGS is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months WGS reported a non-GAAP Earnings per Share(EPS) of 0.84. The EPS increased by 124.14% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -12.47% | ||
ROE | -21.32% | ||
Debt/Equity | 0.29 |
ChartMill assigns a Buy % Consensus number of 76% to WGS. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 308.39% and a revenue growth 23.68% for WGS